advanced search
Dr Nicky Bertollo
Chief Technology Officer and Co-Founder
Pharma Latch

Is this your profile?

About

Nicky Bertollo, PhD (University of New South Wales, Sydney, Australia), is Chief Technology Officer and Co-Founder of Pharma Latch. He is a biomedical engineer with over 20 years’ experience in the design, development, preclinical testing and evaluation of medical devices. Dr Bertollo is the inventor of the Latch platform technology and has built deep domain expertise in ID drug delivery technologies over a number of years. Dr Bertollo leads all the company’s engineering, technical and scientific activities.

Contributions

SKIN
IT’S TIME TO CONSIDER INTRADERMAL DELIVERY
Nicky Bertollo, Adam Rock and Saidhbh O’Callaghan discuss the progress Pharma Latch’s intradermal drug delivery platform is making towards realising the potential the intradermal route offers to drug developers, especially for vaccines.

More contributions

EARLY INSIGHT
HOW DO YOU PERCEIVE INTRADERMAL DELIVERY? THINK AGAIN…
Nicky Bertollo, Adam Rock and Ronan Byrne discuss the benefits and limitations of intradermal delivery – and introduce the Pharma Latch Hollow intradermal injection device.
EARLY INSIGHT
AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY
Nicky Bertollo, Ronan Byrne and Andrew Muddle introduce Pharma Latch – a user-centric angled microneedle patch technology. They discuss its key benefits, such as dramatically increased payload potential, precision, low cost and variable patch-wear times, and highlight how Pharma Latch has the potential to overcome many of the limitations of existing routes of administration for therapeutics and vaccines.
Top